The anti-Her3 antibody specifically target Her3 which is a member of the ErbB protein family. By binding to the Her3, the specific antibody can be used in the treatment of proliferative disorders like cancer.
Figure 1 Activation of NRG1-dependent HER3 abolishes inhibitory effects of trastuzumab in BT474 cells.
p-HER3 was significantly downregulated by HER3 antibody after NRG1 stimulation.
Yang, L., Li, Y., Shen, E., Cao, F., Li, L., Li, X., ... & Li, Q. (2017). NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells. International journal of oncology, 51(5), 1553-1562.
Figure 2 The NRG1-dependent HER3 antibody promotes early apoptosis in BT474 cells.
Without NRG1 stimulation, trastuzumab significantly increased early apoptosis of BT474 cells when compared to the control (P<0.05).
Yang, L., Li, Y., Shen, E., Cao, F., Li, L., Li, X., ... & Li, Q. (2017). NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells. International journal of oncology, 51(5), 1553-1562.
Figure 3 HER3 antibody combined with trastuzumab synergistically inhibits cell viability.
In BT474 cells, the inhibitory effect of trastuzumab on cell viability was gradually enhanced with the increase of drug concentration. However, the effect on MDA-MB-453 cells was weak and stable. After NRG1 combined with trastuzumab, the cell viability was significantly increased in BT474 cells, however, this significant increase was not observed in MDA-MB-453 cells.
Yang, L., Li, Y., Shen, E., Cao, F., Li, L., Li, X., ... & Li, Q. (2017). NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells. International journal of oncology, 51(5), 1553-1562.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-1729-sdAb | Recombinant Anti-human ERBB3 VHH Single Domain Antibody | WB, ICC, ChiP, FA, ELISA | Llama VHH |
TAB-070CT | Llama Anti-ERBB3 Recombinant Single Domain Antibody (TAB-070CT) | FC, Block | Llama VHH |
PABC-556 | Recombinant Llama Anti-ERBB3 Single Domain Antibody (PABC-556) | ELISA, SPR | Llama VHH |
There are currently no Customer reviews or questions for TAB-0509CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.